Table 1. Patient characteristics of the admission glucose groups.

Admission glucose level (mg/dL)	<100 (n = 72)	100 – 139 (n = 345)	140 – 189 (n = 237)	190 – 249 (n = 114)	≥250 (n = 191)	P‐value
Age (years)	61.2 ± 12.9	58.0 ± 12.6	61.7 ± 12.7	62.2 ± 12.2	63.0 ± 12.0	<0.001
Male	64 (88.9)	306 (88.7)	197 (83.1)	90 (78.9)	130 (68.1)	<0.001
Previously recognized diabetes	13 (18.1)	22 (6.4)	50 (21.1)	63 (55.3)	158 (82.7)	<0.001
History of heart failure	4 (5.6)	6 (1.7)	2 (0.8)	7 (6.1)	9 (4.7)	<0.001
Presentation
Typical angina	63 (87.5)	321 (93.0)	214 (90.3)	100 (87.7)	155 (81.2)	0.001
Killip III/IV	14 (19.4)	64 (18.6)	61 (25.7)	36 (31.6)	89 (46.6)	<0.001
Laboratory analysis
Creatine kinase (IU/L)†	1864.3 ± 106.0	2910.0 ± 136.4	2995.2 ± 155.4	2734.2 ± 227.5	3374.8 ± 239.8	0.002
Creatine kinase‐MB (IU/L)†	185.9 ± 19.6	269.8 ± 14.1	260.6 ± 12.8	250.5 ± 24.5	278.0 ± 22.2	0.11
Total cholesterol (mg/dL)	177.5 ± 37.5	187.7 ± 41.5	183.4 ± 40.1	178.9 ± 46.2	189.8 ± 48.3	0.09
Triglyceride (mg/dL)	129.4 ± 85.6	132.7 ± 101.9	130.1 ± 95.7	180.2 ± 177.6	184.5 ± 199.9	<0.001
High‐density lipoprotein (mg/dL)	42.3 ± 16.0	43.4 ± 12.7	43.1 ± 13.8	40.4 ± 12.9	40.3 ± 13.5	0.22
Low‐density lipoprotein (mg/dL)	111.1 ± 34.1	123.0 ± 35.5	117.8 ± 37.7	110.5 ± 39.2	116.7 ± 40.4	0.06
Platelets (K/uL)	235.9 ± 123.8	223.7 ± 68.0	215.0 ± 53.3	226.8 ± 65.6	227.7 ± 82.0	0.24
Medication therapy
Antihypertensive therapy	22 (30.6)	135 (39.1)	94 (39.7)	35 (30.7)	60 (31.4)	0.14
Antidyslipidemic therapy	11 (15.3)	82 (23.8)	59 (24.9)	20 (17.5)	44 (23.0)	0.30
Antidiabetic therapy	13 (18.1)	22 (6.4)	50 (21.1)	63 (55.3)	158 (82.7)	<0.001

Values are presented as n (%) or as mean ± standard deviation (n = 959). †Values are presented as mean ± standard error.